|
시장보고서
Seasonal Influenza Vaccines Market Forecast
|
Abstract
Introduction
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly
in recent years. This growing commercial opportunity has encouraged companies
to develop new technologies and increase manufacturing capacity for influenza
vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but
also confronts industry and public health stakeholders with new challenges.
Key reasons to purchase this research
- Review the clinical and commercial factors driving new product decisions
in influenza vaccines and the strategies of key players in the market
- Size the market with patient-based scenario forecasts of the seasonal
vaccines market and a thorough analysis of the vaccine and antiviral pipeline
- Understand concerns, unmet needs and future opportunities in influenza
prevention and therapy
Table of Contents
OVERVIEW
- This product contains forecasts for seasonal influenza vaccines across the
seven major markets from the influenza season 2009/10 to 2018/19. It has been
designed for delivery in an excel data pack format, but for more detail about
this disease area please see the accompanying Commercial Insight: Influenza
Vaccines and Antivirals word document and PowerPoint executive presentation
(DMHC2516).
- The associated report and PowerPoint presentation can be found under
Latest research in the Knowledge centre, through the search function or by
contacting your sales representative.
- Please select the data pack option from the download menu at the side of
the page to access the model.
- Introduction
- Scope of this research
- Research and analysis highlights
- Key reasons to read this report
- Forecasting Methodology
FIGURES
- Figure: Datamonitor' s patient-based vaccine forecasting model -
influence factors
|
